Corporate insider profile
Christoph Samuel Ziegler Insider Trades
Latest reported as Corporate insider of Veraxa Biotech AG - Post de-SPAC (VRXA).
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $32,700
- Latest transaction
- Oct 20, 2026
Affiliated corporations
Reported company relationships
Transaction history
